Literature DB >> 29778508

Financial toxicity - An overlooked side effect.

Margaret I Liang1, Warner K Huh2.   

Abstract

Entities:  

Keywords:  Financial toxicity; Gynecologic cancer; Out of pocket cost

Mesh：

Year:  2018        PMID： 29778508      PMCID： PMC6524949          DOI： 10.1016/j.ygyno.2018.05.012

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  19 in total

1.  Out-of-pocket health-care expenditures among older Americans with cancer.

Authors:  Kenneth M Langa; A Mark Fendrick; Michael E Chernew; Mohammed U Kabeto; Kerry L Paisley; James A Hayman
Journal:  Value Health       Date:  2004 Mar-Apr       Impact factor: 5.725

2.  Medical bankruptcy in the United States, 2007: results of a national study.

Authors:  David U Himmelstein; Deborah Thorne; Elizabeth Warren; Steffie Woolhandler
Journal:  Am J Med       Date:  2009-06-06       Impact factor: 4.965

3.  The development of a financial toxicity patient-reported outcome in cancer: The COST measure.

Authors:  Jonas A de Souza; Bonnie J Yap; Fay J Hlubocky; Kristen Wroblewski; Mark J Ratain; David Cella; Christopher K Daugherty
Journal:  Cancer       Date:  2014-06-20       Impact factor: 6.860

4.  Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors.

Authors:  Hrishikesh P Kale; Norman V Carroll
Journal:  Cancer       Date:  2016-03-14       Impact factor: 6.860

5.  Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

Authors:  Lowell E Schnipper; Nancy E Davidson; Dana S Wollins; Douglas W Blayney; Adam P Dicker; Patricia A Ganz; J Russell Hoverman; Robert Langdon; Gary H Lyman; Neal J Meropol; Therese Mulvey; Lee Newcomer; Jeffrey Peppercorn; Blase Polite; Derek Raghavan; Gregory Rossi; Leonard Saltz; Deborah Schrag; Thomas J Smith; Peter P Yu; Clifford A Hudis; Julie M Vose; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2016-05-31       Impact factor: 44.544

6.  A phase 3 trial of bevacizumab in ovarian cancer.

Authors:  Timothy J Perren; Ann Marie Swart; Jacobus Pfisterer; Jonathan A Ledermann; Eric Pujade-Lauraine; Gunnar Kristensen; Mark S Carey; Philip Beale; Andrés Cervantes; Christian Kurzeder; Andreas du Bois; Jalid Sehouli; Rainer Kimmig; Anne Stähle; Fiona Collinson; Sharadah Essapen; Charlie Gourley; Alain Lortholary; Frédéric Selle; Mansoor R Mirza; Arto Leminen; Marie Plante; Dan Stark; Wendi Qian; Mahesh K B Parmar; Amit M Oza
Journal:  N Engl J Med       Date:  2011-12-29       Impact factor: 91.245

7.  Incorporation of bevacizumab in the primary treatment of ovarian cancer.

Authors:  Robert A Burger; Mark F Brady; Michael A Bookman; Gini F Fleming; Bradley J Monk; Helen Huang; Robert S Mannel; Howard D Homesley; Jeffrey Fowler; Benjamin E Greer; Matthew Boente; Michael J Birrer; Sharon X Liang
Journal:  N Engl J Med       Date:  2011-12-29       Impact factor: 91.245

8.  Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis.

Authors:  Scott Ramsey; David Blough; Anne Kirchhoff; Karma Kreizenbeck; Catherine Fedorenko; Kyle Snell; Polly Newcomb; William Hollingworth; Karen Overstreet
Journal:  Health Aff (Millwood)       Date:  2013-05-15       Impact factor: 6.301

9.  Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer.

Authors:  Scott D Ramsey; Aasthaa Bansal; Catherine R Fedorenko; David K Blough; Karen A Overstreet; Veena Shankaran; Polly Newcomb
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

10.  Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.

Authors:  Jonathan Ledermann; Philipp Harter; Charlie Gourley; Michael Friedlander; Ignace Vergote; Gordon Rustin; Clare Scott; Werner Meier; Ronnie Shapira-Frommer; Tamar Safra; Daniela Matei; Euan Macpherson; Claire Watkins; James Carmichael; Ursula Matulonis
Journal:  N Engl J Med       Date:  2012-03-27       Impact factor: 91.245
View more
  6 in total

Review 1.  Society of gynecologic oncology future of physician payment reform task force: Lessons learned in developing and implementing surgical alternative payment models.

Authors:  Margaret I Liang; Emeline M Aviki; Jason D Wright; Laura J Havrilesky; Leslie R Boyd; Haley A Moss; Elizabeth L Jewell; David E Cohn; Sachin M Apte; Patrick F Timmins; Ronald D Alvarez; Jill Rathbun; Elizabeth Lipinski; Susan White; Dorimar Siverio-Minardi; Emily M Ko
Journal:  Gynecol Oncol       Date:  2020-01-06       Impact factor: 5.482

2.  Impact of Cost Conversation on Decision-Making Outcomes.

Authors:  Nataly R Espinoza Suarez; Christina M LaVecchia; Karen M Fischer; Celia C Kamath; Juan P Brito
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-06-12

3.  Economic hardships from COVID-19 and its association with socioeconomic factors and diabetes management indicators: A cross-sectional study.

Authors:  Yiqian Xin; Ege K Duman; Xinyi Yan; Enying Gong; Shangzhi Xiong; Xinyue Chen; Truls Østbye; Lijing L Yan
Journal:  Heliyon       Date:  2022-05-18

4.  Financial toxicity: An adverse effect worthy of a black box warning?

Authors:  Joseph A Dottino; J Alejandro Rauh-Hain
Journal:  Gynecol Oncol       Date:  2020-02       Impact factor: 5.482

5.  Measuring Financial Distress and Quality of Life Over Time in Patients With Gynecologic Cancer-Making the Case to Screen Early in the Treatment Course.

Authors:  Margaret I Liang; Sarah S Summerlin; Christina T Blanchard; Teresa K L Boitano; Warner K Huh; Smita Bhatia; Maria Pisu
Journal:  JCO Oncol Pract       Date:  2021-02-17

Review 6.  Burden of Treatment among Elderly Patients with Cancer: A Scoping Review.

Authors:  Adem Sav; Sara S McMillan; Adeola Akosile
Journal:  Healthcare (Basel)       Date:  2021-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.